Introduction

Abstract

This monograph contains a series of papers which address past and current aspects as well as recent advances in tumour therapy with antimetabolites. Almost half a century has elapsed since Farber published the demonstration of efficacy of aminopterin in childhood acute leukaemia. Maybe antimetabolites should be called the “aspirin” of oncology, as they share a long-standing history and are continuously rediscovered as a class of agents.